Trial By Error, by David Tuller

  • Tack’s Take on 2020 Studies; Professor Edwards’ Statement to NICE

    I have been laying low during the recent holiday and coup season. Today I’m watching the impeachment hearings. And I might find it challenging to get back up to full speed until after New Year’s–which for me will be January 20th, or whichever day the White House is finally de-Trumped. For now, here are a…

    Continue reading

  • Psych Issues Do Not Predict ME/CFS, New Chicago Study Shows

    For decades, investigators have argued over the causes of the illness or cluster of illnesses variously called myalgic encephalomyelitis (ME), chronic fatigue syndrome (CFS),  ME/CFS, CFS/ME and other names. In the absence of an adequate explanation for the debilitating symptoms, a flawed approach to intervention based on the perceived need for psychological and behavioral rehabilitation…

    Continue reading

  • Swedish ME Patient Fears Forced Psychiatric Treatment

    Holger Klintenberg, a 35-year-old from the southern Swedish city of Jonkoping, has severe ME. His illness began after a bout of mononucleosis (or glandular fever) when he was 19. He has recently experienced difficult interactions with the health care system. His family fears he could be forced into psychiatric care against his and their wishes.…

    Continue reading

  • A Letter to BMJ From Prof Hughes, Prof Racaniello and Me

    I have sent the following letter to Fiona Godlee, editorial director of BMJ and editor-in-chief of The BMJ, on behalf of Professors Brian Hughes and Vincent Racaniello as well as me. We were responding to the recent editorial regarding the new draft of ME/CFS clinical guidelines from the National Institute for Health and Care Excellence–as…

    Continue reading

  • BMJ Pushes Back Against New NICE Draft

    The BMJ has published an online “editorial” slamming the new draft of clinical guidelines for ME/CFS from the National Institute for Health and Care Excellence. The position expressed is an interesting one: Non-pharmacological treatments for “complex conditions” cannot be adequately measured by randomized trials, according to the two authors. It is, of course, noteworthy that…

    Continue reading

  • Professors Chalder and Crawley Join Forces to Push CBT for Kids

    On November 10th, the National Institute of Health and Care Excellence published a draft of new clinical guidelines for ME/CFS. The draft represented a blunt rejection of the argument that the combination of “unhelpful cognitions” and deconditioning drives the illness. Under this once-hegemonic framework, indicated therapies include cognitive behavior therapy to overcome the unhelpful cognitions…

    Continue reading

  • Letter to Author of Removed GET/CBT Training Program for GPs

    Earlier today, I posted a blog about the decision by the Royal College of General Practice to remove from its site a training program called METRIC, which promoted the GET/CBT approach. I then sent the following letter to Carolyn Chew-Graham, a professor of general practice research at Keele University in Staffordshire and the main author…

    Continue reading

  • GP Group Removes Online GET/CBT Medical Training Program

    In early 2019, I wrote about an awful online training course for general practitioners on recognizing and caring for patients diagnosed with what was referred to as CFS/ME. The module, called METRIC, promised to provide “GPs and other primary care practitioners with an overview of the presentation, diagnosis, assessment and ongoing management” of the illness.…

    Continue reading

  • My Zoom-Talk on the NICE Draft for Sheffield ME Group

    On Monday, I gave a Zoom-talk hosted by the Sheffield ME & Fibromyalgia Group on the new draft of ME/CFS clinical guidelines from UK’s National Institute of Health and Care Excellence. The draft rejected the GET/CBT treatment paradigm. I haven’t watched the video, but most likely one of my eyebrows is hopping up and down…

    Continue reading

  • FDA Approves Web-CBT for IBS; GET/CBT as Tomorrow’s “Rubbish”

    Mahana set to announce FDA approval for ineffective IBS program Earlier this year, I spent a lot of time blogging about the unethical and dishonest manner in which a San Francisco start-up called Mahana Therapeutics was promoting an eight-week web-based program of cognitive behavior therapy for patients suffering from irritable bowel syndrome. The company had…

    Continue reading

  • Thoughts on The Observer, The Guardian, and Paradigm Shift

    Earlier this week, I blogged about a story in The Observer that provided an inaccurate description of what it called chronic fatigue syndrome. For much of the piece, the writer, Eleanor Morgan, offered a sympathetic portrait of people, including herself, experiencing prolonged symptoms after an acute bout of Covid-19. A lot of what she presented…

    Continue reading

  • The Observer Slips Up; ME Association Responds

    News organizations continue to misrepresent ME (and its various iterations) in their coverage of what has come to be called long-Covid. A current UK example is Sunday’s Observer article by writer Eleanor Morgan, who is experiencing prolonged symptoms since falling ill last spring. (It’s on The Guardian site; the two organizations are linked in some…

    Continue reading